ORBERA365

DEVICE2 trials

Sponsors

Apollo Endosurgery, Inc., Kaiser Clinic and Hospital

Conditions

ObesityObesity, MorbidOverweight

Unknown Phase

ORBERA365 Post-Marketing Clinical Follow-up Study

TerminatedNCT04362774

Apollo Endosurgery, Inc.Obesity, Overweight

Start: 2021-02-23End: 2023-10-10Updated: 2024-12-31

Endoscopic Treatment of Overweight and Mild Obesity with ORBERA365

RecruitingNCT06785233

Kaiser Clinic and HospitalObesity, Obesity, Morbid

Start: 2025-01-31End: 2026-02-28Target: 30Updated: 2025-01-21